Black Rock Inc. Prelude Therapeutics Inc Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Black Rock Inc. holds 1,068,916 shares of PRLD stock, worth $983,402. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,068,916

Previous 1,097,474 2.6%

Holding current value

$983,402

Previous $5.2 Million 21.72%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$3.32 - $5.63 $94,812 - $160,781	-28,558 Reduced 2.6%	1,068,916 $4.07 Million
Q1 2024 May 10, 2024	BUY	$2.68 - $4.84 $5,051 - $9,123	1,885 Added 0.17%	1,097,474 $5.2 Million
Q4 2023 Feb 13, 2024	BUY	$1.69 - $4.37 $45,891 - $118,667	27,155 Added 2.54%	1,095,589 $4.68 Million
Q3 2023 Nov 13, 2023	BUY	$2.74 - $4.79 $573,517 - $1 Million	209,313 Added 24.36%	1,068,434 $3.3 Million
Q2 2023 Aug 11, 2023	BUY	$4.45 - $8.12 $1.94 Million - $3.54 Million	436,093 Added 103.09%	859,121 $3.87 Million
Q1 2023 May 12, 2023	BUY	$4.58 - $7.34 $134,995 - $216,346	29,475 Added 7.49%	423,028 $2.41 Million
Q4 2022 Feb 13, 2023	SELL	$4.61 - $8.5 $302,328 - $557,438	-65,581 Reduced 14.28%	393,553 $2.38 Million
Q3 2022 Nov 14, 2022	SELL	$5.0 - $8.82 $351,505 - $620,054	-70,301 Reduced 13.28%	459,134 $3.03 Million
Q2 2022 Aug 12, 2022	SELL	$4.0 - $7.55 $2.09 Million - $3.95 Million	-522,525 Reduced 49.67%	529,435 $2.76 Million
Q1 2022 May 12, 2022	BUY	$6.9 - $13.22 $1.07 Million - $2.06 Million	155,456 Added 17.34%	1,051,960 $7.26 Million
Q4 2021 Feb 10, 2022	BUY	$11.89 - $31.74 $2.03 Million - $5.41 Million	170,542 Added 23.49%	896,504 $11.2 Million
Q3 2021 Nov 09, 2021	BUY	$25.78 - $38.65 $596,033 - $893,588	23,120 Added 3.29%	725,962 $22.7 Million
Q2 2021 Aug 11, 2021	BUY	$28.63 - $44.3 $20.1 Million - $31.1 Million	702,842 New	702,842 $20.1 Million

Others Institutions Holding PRLD

# of Institutions

Shares Held

28.3M

Call Options Held

23.9K

Put Options Held

View Full List

About Prelude Therapeutics Inc

Ticker PRLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,369,200
Market Cap $33.5M
Description
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...

More about PRLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account